The Impact of Atorvastatin on Intraprostatic Biomarkers - Prognostic Value of 3LS-score - Follow-up of ESTO1-Trial.

Neoplasia · 2025 · PMC11851191 · PMID 39919693

Europe PMC DOI

hedged sentence

0.1950

closest p · 3.9× alpha

0.1950

boldest claim

The sentences

did not reach statistical significancep=0.195not close (p > 0.1)

Impact of Atorvastatin and Atorvastatin Lactone Concentrations on Prostate Tissue Markers Patients with measurable intraprostatic concentrations of atorvastatin exhibited lower median Ki67 values compared to those with non-measurable concentrations, although the difference did not reach statistical significance (p=0.195) ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.